Sign In
Buy CRIS
$0.500
-0.0025 (-0.498%)
At Close: Jun 03, 2026
Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
01:00pm, Thursday, 27'th Feb 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into a common stock purchase
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-Diagnostics Inc (NASDAQ: CODX ) Fat
Curis Reports $30M Common Stock Purchase Deal With Aspire Capital Fund
12:00am, Thursday, 27'th Feb 2020Curis and Aurigene amend collaboration agreement on NSCLC candidate CRIS
01:33pm, Thursday, 06'th Feb 2020
Curis and Aurigene amend collaboration agreement on NSCLC candidate CRIS
Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170
01:30pm, Thursday, 06'th Feb 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into an amendment of its coll
Curis And Aurigene Announce Amendment Of Collaboration For The Development And Commercialization Of CA-170
12:00am, Thursday, 06'th Feb 2020
Curis, Inc (NASDAQ: CRIS) and DarwinHealth, Inc. today announced a multi-year scientific research collaboration to use quantitative, systems biology-based algorithms, CLIA-approved technologies, and n
Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies
01:05pm, Tuesday, 07'th Jan 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into an option and license ag
Curis Announces Option And License Agreement With ImmuNext For Development And Commercialization Of Anti-VISTA Antibodies
12:00am, Tuesday, 07'th Jan 2020Should You Buy Curis, Inc. (CRIS)?
11:24pm, Monday, 23'rd Dec 2019
We can judge whether Curis, Inc. (NASDAQ:CRIS) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to ge
The Curis (NASDAQ:CRIS) Share Price Is Up 103% And Shareholders Are Boasting About It
01:33pm, Sunday, 22'nd Dec 2019
Some Curis, Inc. (NASDAQ:CRIS) shareholders are probably rather concerned to see the share price fall 37% over the...
The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling
12:00am, Saturday, 07'th Dec 2019
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced updated preliminary data from its ongoing Phase 1
